Oneliner_1150

OneLiner

Monoclonal antibody therapies, such as daclizumab, directly bind to the interleukin-2 (IL-2) receptor and prevent clonal expansion of T lymphocytes. Although tacrolimus also affects the action of IL-2, it does not directly bind the IL-2 receptor.